ATF5 and central nervous system cancer: Indeed, analysis of ATF5 promoter methylation in glioma revealed that there is a substantial decrease in promoter methylation in high grade gliomas relative to low grade gliomas and normal tissue, thereby suggesting alterations in promoter methylation drive aberrant ATF5 expression in high grade gliomas [49].